Evidence map›Paper›PMID 25137422›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2014

Parathyroid hormone 1-84 alters circulating vascular endothelial growth factor levels in hypoparathyroidism.

Natalie E Cusano, Mishaela R Rubin, Chiyuan Zhang, Laura Anderson, Elizabeth Levy, Aline G Costa, Dinaz Irani, John P Bilezikian

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Natalie E CusanoDivision of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
Mishaela R Rubin
Chiyuan Zhang
Laura Anderson
Elizabeth Levy
Aline G Costa
Dinaz Irani
John P Bilezikian
Columbia University · US

Funding

Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
BONE PROPERTIES IN HYPOPARATHYROIDISM: EFFECTS OF PTHR01DK069350 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BILEZIKIAN, JOHN P · 2005 to 2014
$6.1M
NCATS NIH HHS UL1 TR000040NIDDK NIH HHS DK069350NIDDK NIH HHS R01 DK069350PHS HHS FDA002525
6 · The paper itself

Abstract

contextWe previously reported on four patients treated with PTH(1-84) who recovered from postoperative hypoparathyroidism many years after onset. Because vascular endothelial growth factor (VEGF) has been shown to be necessary for the induction of PTH-mediated angiogenesis, we postulated a possible role for VEGF in the recovery of parathyroid function in these subjects.

objectiveOur objective was to measure VEGF levels in subjects with hypoparathyroidism who regained parathyroid gland function and matched controls. SETTING AND

designSubjects with hypoparathyroidism who regained parathyroid gland function were each matched to two hypoparathyroid controls by postoperative etiology, age (within 5 y), menopausal status, and duration of hypoparathyroidism. We measured serum VEGF levels at baseline and through 48 months of PTH(1-84) therapy.

resultsVEGF levels increased after the initiation of PTH(1-84) therapy for the entire cohort, from 309.7 ± 162 pg/ml at baseline to 380.2 ± 178 pg/ml at 12 months (P = .03). Levels trended downward thereafter. There were no significant differences in VEGF levels between the subjects with recovery of parathyroid function and the matched controls.

conclusionsPTH(1-84) alters serum VEGF levels in subjects with hypoparathyroidism. Additional investigation is necessary to understand the mechanisms by which some subjects with postoperative hypoparathyroidism recover parathyroid gland function.

Indexed as

AdultAgedFemaleHumansHypoparathyroidismInjections, SubcutaneousMenopauseMiddle AgedNeovascularization, PhysiologicParathyroidectomyParathyroid GlandsParathyroid HormoneRecombinant ProteinsThyroid NeoplasmsVascular Endothelial Growth Factor AParathyroid HormoneRecombinant ProteinsVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID25137422
PMCPMC4184068
OpenAlexW2029753751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.